Evidence map›Paper›PMID 33808002›Full record

ArticleInternational journal of neonatal screening2021

Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010.

J Gerard Loeber, Dimitris Platis, Rolf H Zetterström, Shlomo Almashanu, François Boemer, James R Bonham, Patricia Borde, Ian Brincat, David Cheillan, Eugenie Dekkers and 37 more

Abstract read
In one paragraph

Article in International journal of neonatal screening, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Detection of AdenoviralInternational journal of molecular sciences · 2026
    Article
  14. Review
  15. Current Status of Newborn Screening in Southeastern and Central Europe.International journal of neonatal screening · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

J Gerard LoeberInternational Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands.
Dimitris PlatisDepartment of Newborn Screening, Institute of Child Health, 11527 Athens, Greece.
Rolf H ZetterströmCentre for Inherited Metabolic Diseases, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institute, SE-17 76 Stockholm, Sweden.ORCID 0000-0002-3016-0019
Shlomo AlmashanuNewborn Screening Laboratories, Tel-HaShomer, 52621 Ramat Gan, Israel.
François BoemerCHU-Domaine du Sart Tilman, 4000 Liège, Belgium.ORCID 0000-0003-4470-9524
James R BonhamSheffield Children's NHS Foundation Trust, Sheffield S10 2TH, UK.
Patricia BordeLaboratoire National de Santé, 3555 Dudelange, Luxembourg.
Ian BrincatMater Dei Hospital, Tal-Qroqq Msida, MSD2090 Msida, Malta.
David CheillanGroupement Hospitalier Est, 69500 Bron, France.
Eugenie DekkersCentre for Population Research, National Institue for Public Health and the Environment (RIVM), 3720BA Bilthoven, The Netherlands.
Dobry DimitrovNational Genetic Laboratory, Hospital Maichin Dom, 1431 Sofia, Bulgaria.
Ralph FingerhutNeonatal Screening Laboratory, Children's Hospital, CH-8032 Zürich, Switzerland.
Leifur FranzsonDepartment Genetics & Molecular Medicine, Landspitali, Reykjavik 108, Iceland.ORCID 0000-0001-9986-1377
Urh GroseljUniversity Children's Hospital, 1000 Ljubljana, Slovenia.ORCID 0000-0002-5246-9869
David HougaardStaten Serum Institute, 2300 Copenhagen, Denmark.
Maria KnapkovaNewborn Screening Centre, Banska Bystrica 97401, Slovakia.ORCID 0000-0002-8917-4589
Mirjana KocovaMedical Faculty, 1000 Skopje, North Macedonia.ORCID 0000-0001-7097-3439
Vjosa KotoriUniversity Clinical Centre, Pristina 10000, Kosovo.
Viktor KozichDepartment of Pediatrics and Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital, Prague 12808, Czech Republic.ORCID 0000-0001-5820-5277
Anastasiia KremeznaClinical and Diagnostic Center "Pharmbiotest", LLC 93000 Rubizhne, Ukraine.
Riikka KurkijärviNewborn Screening Centre, Turku University Hospital, 20521 Turku, Finland.
Giancarlo La MarcaMeyer Hospital, 50139 Florence, Italy.
Ruth MikelsaarMedical Faculty, University of Tartu, 50411 Tart, Estonia.
Tatjana MilenkovicMother and Child Health Care Institute of Serbia, Belgrade 11070, Serbia.
Vyacheslav MitkinNeonatal Screening Center, 115580 Moscow, Russia.
Florentina MoldovanuNational Institute for Mother and Child Health, 050474 Bucharest, Romania.
Uta CeglarekUniversity Clinic, 04103 Leipzig, Germany.
Loretta O'GradyNewborn Blood Spot Screening Laboratory, Dublin 1, Ireland.
Mariusz OltarzewskiInstitute of Mother and Child, 01-211 Warsaw, Poland.
Rolf D PettersenNorwegian National Unit for Newborn Screening, 0424 Oslo, Norway.
Danijela RamadzaUniversity Hospital Medical Centre Zagreb, 10000 Zagreb, Croatia.
Damilya SalimbayevaRepublican Scientific Centre for Gynaecology and Perinatology, Almaty 050020, Kazakhstan.ORCID 0000-0002-7933-3654
Mira SamardzicInstitute for Sick Children, 81000 Podgorica, Montenegro.ORCID 0000-0001-5685-6324
Markhabo ShamsiddinovaRepublican Center Mother and Child Screening, Tashkent 100164, Uzbekistan.ORCID 0000-0002-2922-8100
Jurgita SongailienéCentre for Medical Genetics, 08661 Vilnius, Lithuania.
Ildiko SzatmariChildren's Clinic, 1083 Budapest, Hungary.
Nazi TabatadzeNeugoGenetic and Metabolic Center, Tbilisi 0194, Georgia.
Basak TezelChild and Adolescent Health Department, 06430 Ankara, Turkey.
Alma ToromanovicDepartment of Pediatrics, University Clinical Centre, Tuzla 75000, Bosnia and Herzegovina.
Irina TovmasyanArbes Health Care Centre, Yerevan 0014, Armenia.
Natalia UsureluNational Centre Health and Reproductive & Medical Genetics, 2062 Chisinau, Moldova.
Parsla VevereChildren's University Hospital, 1004 Riga, Latvia.
Laura VilarinhoNational Institute of Health, 4000-055 Porto, Portugal.ORCID 0000-0001-6186-779X
Marios VogazianosCenter for Preventive Paediatrics, 3022 Limassol, Cyprus.
Raquel YahyaouiMálaga Regional University Hospital. Institute of Biomedical Research IBIMA, 29011 Málaga, Spain.ORCID 0000-0001-6789-1563
Maximilian ZeydaDepartment of Pediatrics and Adolescent Medicine, 1090 Vienna, Austria.ORCID 0000-0001-5000-1974
Peter C J I SchielenInternational Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands.ORCID 0000-0002-5630-7322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.

Indexed as

congenital endocrine disorderscongenital metabolic disordersdried blood spot screeningInternational Society for Neonatal ScreeningISNSneonatal screeningnewborn screeningpublic healthrare diseases

Identifiers

PMID33808002
PMCPMC8006225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.